Related references
Note: Only part of the references are listed.The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation
Christopher M. Henstridge et al.
FASEB JOURNAL (2009)
TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons
Helen E. Gibson et al.
NEURON (2008)
Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: Opioid receptor dependency and molecular correlates
Ryan K. Butler et al.
PAIN (2008)
The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain
Penny C. Staton et al.
PAIN (2008)
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current
Jane E. Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The dorsal periaqueductal and basolateral amygdala are necessary for the expression of conditioned place avoidance induced by semicarbazide stimulation of the dorsal periaqueductal region
Janaina M. Zanoveli et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The effect of CB1 receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats
Michelle Roche et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat
Michelle Roche et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Cb1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception
Parisa Hasanein et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
Altered pain processing in veterans with posttraumatic stress disorder
Elbert Geuze et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids
Michelle Roche et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Blockade of cannabinoid CB1 receptors alters contextual learning and memory
Jeremy D. Arenos et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Effects of intra-amygdala infusion of CB1 receptor agonists on the reconsolidation of fear-potentiated startle
Hui-Ching Lin et al.
LEARNING & MEMORY (2006)
Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia
K Connell et al.
NEUROSCIENCE LETTERS (2006)
Behavioral central monoaminergic and hypothalamo-pituitary-adrenal axis correlates of fear-conditioned analgesia in rats
DP Finn et al.
NEUROSCIENCE (2006)
Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: Sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla
RL Suplita et al.
NEUROPHARMACOLOGY (2005)
Endocannabinoid signaling in rat somatosensory cortex:: Laminar differences and involvement of specific interneuron types
AL Bodor et al.
JOURNAL OF NEUROSCIENCE (2005)
Effect of the cannabinoid CB1 receptor antagonist, SR141716, on nociceptive response and nerve demyelination in rodents with chronic constriction injury of the sciatic nerve
B Costa et al.
PAIN (2005)
An endocannabinoid mechanism for stress-induced analgesia
AG Hohmann et al.
NATURE (2005)
Hippocampal neurokinin-1 receptor and brain-derived neurotrophic factor gene expression is decreased in rat models of pain and stress
V Duric et al.
NEUROSCIENCE (2005)
Amygdalar lateralization in fear conditioning: Evidence for greater involvement of the right amygdala
KB Baker et al.
BEHAVIORAL NEUROSCIENCE (2004)
CBI cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice
A Cannich et al.
LEARNING & MEMORY (2004)
Evidence for differential modulation of conditioned aversion and fear-conditioned analgesia by CB1 receptors
DP Finn et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Contributions of the anterior cingulate cortex and amygdala to pain- and fear-conditioned place avoidance in rats
YJ Gao et al.
PAIN (2004)
Circuitry for associative plasticity in the amygdala involves endocannabinoid signaling
SC Azad et al.
JOURNAL OF NEUROSCIENCE (2004)
NMDA receptors in the anterior cingulate cortex mediate pain-related aversion
LG Lei et al.
EXPERIMENTAL NEUROLOGY (2004)
Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats
DP Finn et al.
NEUROPHARMACOLOGY (2003)
Differential patterns of c-fos mRNA expression in the amygdaloid nuclei induced by chemical somatic and visceral noxious stimuli in rats
T Nakagawa et al.
NEUROSCIENCE LETTERS (2003)
The rodent amygdala contributes to the production of cannabinoid-induced antinociception
BH Manning et al.
NEUROSCIENCE (2003)
The endogenous cannabinoid system controls extinction of aversive memories
G Marsicano et al.
NATURE (2002)
Dorsolateral and ventral regions of the periaqueductal gray matter are involved in distinct types of fear
DML Vianna et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2001)
Blocking NMDA receptors in the hippocampal dentate gyrus with AP5 produces analgesia in the formalin pain test
JE McKenna et al.
EXPERIMENTAL NEUROLOGY (2001)
The affective component of pain in rodents: Direct evidence for a contribution of the anterior cingulate cortex
JP Johansen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism
L De Petrocellis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
GABAergic modulation of descending inhibitory systems from the rostral ventromedial medulla (RVM). Dose-response analysis of nociception and neurological deficits
AK Gilbert et al.
PAIN (2001)
Role of the endogenous cannabinoid system in the formalin test of persistent pain in the rat
P Beaulieu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
